AVAI logo

Avant Technologies Inc. (AVAI) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $0.32, Avant Technologies Inc. (AVAI) es una empresa del sector Technology valorada en 45M. Calificado con 42/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 15 mar 2026
Puntuación de IA de 42/100 MCap 45M Vol 5K

Perfil Tecnológico y Posición Competitiva de Avant Technologies Inc. (AVAI)

Sede CentralVilnius, Lithuania

Avaí Bio, Inc., based in Vilnius, Lithuania, specializes in AI technology development and IT consulting. The company offers full-stack software solutions, database management, and its Avant! AI platform. With a market capitalization of $0.05 billion, Avaí Bio operates in the competitive application software sector, focusing on AI-driven innovations.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 15 mar 2026

Tesis de Inversión

Avaí Bio, Inc. presents a speculative investment opportunity within the AI and IT consulting sectors. The company's focus on AI technology development, particularly the Avant! AI platform, could drive future growth, though specific performance metrics are not available. With a market capitalization of $0.05 billion and negative free cash flow, the company's financial position requires careful monitoring. Key catalysts include successful commercialization of Avant! AI and strategic acquisitions to expand its technology portfolio. Potential risks include competition in the AI space and the challenges of integrating acquired technologies. Investors should carefully assess the company's ability to execute its growth strategy and achieve profitability.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $0.05 billion, indicating a small-cap company.
  • Negative Free Cash Flow (FCF) of $0.00 billion, suggesting the company is not currently generating positive cash flow from operations.
  • Beta of 1.06, implying the stock's volatility is similar to the overall market.
  • The company rebranded from Avant Technologies Inc. to Avaí Bio, Inc. in February 2026, reflecting a strategic shift towards biotechnology and AI.
  • Avaí Bio, Inc. offers Avant! AI, a platform that aims to deliver enhanced technology usage, access, and performance.

Fortalezas

  • Focus on artificial intelligence (AI) technologies.
  • Offers a range of IT consulting services.
  • Provides full-stack software development capabilities.
  • Avant! AI platform with potential for enhanced technology usage.

Debilidades

  • Negative Free Cash Flow (FCF) indicating financial challenges.
  • Limited information available on the performance of Avant! AI.
  • Small market capitalization, making it vulnerable to market fluctuations.
  • Reliance on acquisitions for growth, which can be risky.

Catalizadores

  • Upcoming: Potential partnerships with established technology vendors to integrate Avant! AI into existing software ecosystems.
  • Ongoing: Development and release of new AI-powered applications for specific industries.
  • Ongoing: Strategic acquisitions of complementary AI technologies and IT consulting firms to expand market reach.
  • Ongoing: Expansion of IT consulting services to new geographic markets with high demand.
  • Ongoing: Continued refinement and enhancement of the Avant! AI platform.

Riesgos

  • Potential: Intense competition in the AI and IT consulting markets could limit market share.
  • Potential: Rapid technological advancements may render existing solutions obsolete.
  • Potential: Economic downturns could reduce demand for IT services and AI solutions.
  • Ongoing: Negative Free Cash Flow (FCF) indicating financial challenges and potential need for additional funding.
  • Ongoing: Lower liquidity and greater price volatility associated with trading on the OTCQB market.

Oportunidades de crecimiento

  • Growth opportunity 1: Successful commercialization of Avant! AI represents a significant growth opportunity for Avaí Bio. The platform's ability to deliver enhanced technology usage, access, and performance could attract businesses seeking to leverage AI for various applications. While specific market size data for AI platforms is not available, the broader AI market is projected to experience substantial growth in the coming years. The timeline for commercialization will depend on the company's ability to refine the platform and secure partnerships with key customers.
  • Growth opportunity 2: Strategic acquisitions of complementary AI technologies and IT consulting firms could accelerate Avaí Bio's growth. By acquiring companies with established customer bases and specialized expertise, Avaí Bio can expand its market reach and enhance its service offerings. The market for technology acquisitions remains active, with numerous opportunities to acquire innovative companies. The timeline for acquisitions will depend on the company's ability to identify suitable targets and secure financing.
  • Growth opportunity 3: Expansion of IT consulting services to new geographic markets represents another growth opportunity for Avaí Bio. By targeting regions with high demand for IT services and limited competition, the company can increase its revenue and market share. The global IT services market is projected to continue growing in the coming years, driven by digital transformation initiatives and the increasing complexity of IT infrastructure. The timeline for geographic expansion will depend on the company's ability to establish a local presence and adapt its services to meet the specific needs of each market.
  • Growth opportunity 4: Development of new AI-powered applications for specific industries could create new revenue streams for Avaí Bio. By focusing on niche markets with unmet needs, the company can differentiate itself from competitors and capture a significant share of the market. The market for AI-powered applications is rapidly evolving, with new opportunities emerging across various industries. The timeline for developing new applications will depend on the company's ability to identify promising market segments and develop innovative solutions.
  • Growth opportunity 5: Leveraging partnerships with established technology vendors to integrate Avant! AI into existing software ecosystems could drive adoption and generate revenue. By collaborating with companies that have a large customer base and a strong market presence, Avaí Bio can reach a wider audience and accelerate the commercialization of its AI platform. The market for technology partnerships is highly competitive, but successful collaborations can create significant value for both parties. The timeline for establishing partnerships will depend on the company's ability to demonstrate the value of its AI platform and negotiate favorable terms.

Oportunidades

  • Growing demand for AI-powered solutions across various industries.
  • Expansion of IT consulting services to new markets.
  • Strategic partnerships with established technology vendors.
  • Development of new AI applications for specific industries.

Amenazas

  • Intense competition in the AI and IT consulting markets.
  • Rapid technological advancements that could render existing solutions obsolete.
  • Economic downturns that could reduce demand for IT services.
  • Challenges in integrating acquired technologies and companies.

Ventajas competitivas

  • Proprietary AI technology through its Avant! AI platform.
  • Expertise in full-stack software development and IT consulting.
  • Strategic acquisitions of complementary technologies and companies.
  • Established presence in the IT consulting market.

Acerca de AVAI

Avaí Bio, Inc., incorporated in 2017 and based in Vilnius, Lithuania, is a technology company focused on acquiring, creating, and developing artificial intelligence (AI) technologies. Originally founded as Avant Technologies Inc., the company rebranded to Avaí Bio, Inc. in February 2026, signaling a strategic shift towards biotechnology and AI. The company offers a range of information technology (IT) consulting services, including full-stack software development, database management, data integration, project management, and cloud services resources. Avaí Bio's product portfolio includes Avant! AI, an AI platform designed to deliver enhanced technology usage, access, and performance. Additionally, the company offers InstantFAME, though specific details of this product are not provided. Avaí Bio aims to provide comprehensive technology solutions and consulting services to businesses seeking to leverage AI and advanced IT capabilities. The company operates primarily in the technology sector, focusing on software applications and AI-driven solutions. Avaí Bio seeks to establish itself as a key player in the AI technology space through strategic acquisitions and internal development efforts.

Qué hacen

  • Acquires and develops artificial intelligence (AI) technologies.
  • Offers information technology (IT) consulting services.
  • Provides full-stack software development.
  • Offers database management services.
  • Provides data integration solutions.
  • Offers project management resources.
  • Provides cloud services resources.
  • Offers Avant! AI, an AI platform.

Modelo de Negocio

  • Provides IT consulting services on a project basis or through managed services agreements.
  • Generates revenue from the sale or licensing of its AI platform, Avant! AI.
  • Acquires and develops AI technologies, potentially monetizing them through licensing or sale.
  • Offers software development services to clients.

Contexto de la Industria

Avaí Bio, Inc. operates within the application software industry, a segment of the broader technology sector characterized by rapid innovation and intense competition. The global application software market is projected to reach hundreds of billions of dollars in the coming years, driven by increasing demand for cloud-based solutions, AI-powered applications, and digital transformation initiatives. Avaí Bio's focus on AI technology aligns with these trends, but the company faces competition from established players and emerging startups. The company's success will depend on its ability to differentiate its AI offerings and effectively market its IT consulting services.

Clientes Clave

  • Businesses seeking to leverage AI for various applications.
  • Organizations requiring IT consulting services.
  • Companies needing software development and database management solutions.
  • Clients looking for data integration and project management support.
Confianza de la IA: 66% Actualizado: 15 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Avant Technologies Inc. (AVAI): $0.32 (-0.03, -9.50%)

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para AVAI.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para AVAI.

MoonshotScore

42/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de AVAI en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Información del mercado OTC de AVAI

The OTCQB Venture Market is the middle tier of the over-the-counter (OTC) market for U.S. companies. OTCQB companies must meet certain financial reporting standards, undergo annual verification and management certification, and meet a minimum bid price test. This tier offers more transparency than the Pink market but less than the major exchanges like NYSE or NASDAQ. Companies on OTCQB are generally early-stage or developing companies.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Trading volume for OTC stocks can be highly variable. Liquidity on the OTCQB market is generally lower than on major exchanges, which can lead to wider bid-ask spreads and greater price volatility. Investors may experience difficulty in buying or selling large quantities of AVAI shares without significantly impacting the price. Careful monitoring of trading volume and order execution is recommended.
Factores de riesgo OTC:
  • Lower liquidity compared to major exchanges, potentially leading to difficulty in buying or selling shares.
  • Less stringent listing requirements than NYSE or NASDAQ, increasing the risk of financial instability.
  • Greater price volatility due to lower trading volume and market capitalization.
  • Potential for limited analyst coverage and investor awareness.
  • Risk of delisting if the company fails to meet OTCQB requirements.
Lista de verificación de diligencia debida:
  • Verify the company's financial reporting and disclosures on the OTC Markets Group website.
  • Review the company's business plan and growth strategy.
  • Assess the company's management team and their track record.
  • Analyze the company's competitive position within the AI and IT consulting markets.
  • Evaluate the company's capital structure and ability to raise additional funding.
  • Monitor the company's trading volume and price volatility.
  • Consult with a financial advisor to assess the risks and potential rewards of investing in AVAI.
Señales de legitimidad:
  • Current disclosure status on the OTCQB market.
  • Company's focus on artificial intelligence (AI) technologies, a high-growth sector.
  • Provision of IT consulting services, indicating a revenue-generating business.
  • Rebranding to Avaí Bio, Inc. to reflect a strategic focus on biotechnology and AI.
  • Incorporation in 2017, suggesting a relatively established operating history.

Acciones de Avant Technologies Inc.: Preguntas Clave Respondidas

¿Cuáles son los factores clave para evaluar AVAI?

Avant Technologies Inc. (AVAI) actualmente tiene una puntuación IA de 42/100, indicando puntuación baja. Fortaleza clave: Focus on artificial intelligence (AI) technologies.. Riesgo principal a monitorear: Potential: Intense competition in the AI and IT consulting markets could limit market share.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de AVAI?

AVAI actualmente puntúa 42/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de AVAI?

Los precios de AVAI se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre AVAI?

La cobertura de analistas para AVAI incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en AVAI?

Las categorías de riesgo para AVAI incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition in the AI and IT consulting markets could limit market share.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de AVAI?

La relación P/E para AVAI compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está AVAI sobrevalorada o infravalorada?

Determinar si Avant Technologies Inc. (AVAI) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de AVAI?

Avant Technologies Inc. (AVAI) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Limited financial data available for in-depth analysis.
  • OTC market carries higher risks than major exchanges.
Fuentes de datos

Popular Stocks